Hybrid Coronary Percutaneous Treatment With Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-Years Results From the GABI-R Registry

Journal of Clinical Medicine
doi 10.3390/jcm8060767